DJIA 17,976.31 263.65 1.49%
NASDAQ 4,947.44 56.22 1.15%
S&P 500 2,086.24 25.22 1.22%
market minute promo

RECEPTOS INC (NASDAQ: RCPT)

160.05 12.62 (8.56%)

Quote as of


company name or ticker

Recent Quotes

RCPT $160.05 8.56%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $150.00
Previous Close $147.43
Daily Range $150.00 - $160.90
52-Week Range $24.53 - $160.90
Market Cap $5.0B
P/E Ratio -31.84
Dividend (Yield) $0.00 (0.0%)
Volume 1,321,912
Average Daily Volume 680,238
Current FY EPS -$5.43

Sector

Industry

RECEPTOS INC (RCPT) Description

RECEPTOS INC Website: http://www.receptos.com/

News & Commentary Rss Feed

Could This Study Help Lead to a Cure for Select Multiple Sclerosis Patients?

Despite plenty of research dollars being spent, little is still known about the root causes of multiple sclerosis. That's why this latest study is so encouraging for a select group of MS patients, as it may one day lead to a cure.

Receptos (RCPT) In A Perilous Reversal

Jim Cramer's Top Takeaways: Starbucks, Magellan Mainstream, Regeneron

Today Receptos (RCPT) Hits New Lifetime High

Receptos' (RCPT) CEO Faheem Hasnain on Q4 2014 Results - Earnings Call Transcript

UPDATE: Receptos Posts Wider Q4 Loss

After-Hours Earnings Report for March 3, 2015 : MIDD, RCPT, ASNA, AMBA, VEEV, ABM, SQM, BOBE, ZLTQ,

After-Hours Earnings Report for March 3, 2015 : MIDD, RCPT, ASNA, AMBA, VEEV, ABM, SQM, BOBE, ZLTQ, TIVO, FOLD, SWHC

Looking Ahead of Wall Street: Salix Pharmaceuticals, Receptos, Tetraphase

Receptos Gains 2%, CEO Touts Phase II Trials

Biotech Stock Mailbag: Receptos, Celldex Therapeutics, Exact Sciences

See More RCPT News...